<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02175420</url>
  </required_header>
  <id_info>
    <org_study_id>BCG-TFV1</org_study_id>
    <nct_id>NCT02175420</nct_id>
  </id_info>
  <brief_title>Role of BCG as Booster Vaccination</brief_title>
  <official_title>Role of BCG Vaccination as Booster on Salmonella Typhi Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BCG (bacillus Calmette-Guerin) vaccine is used for the protection against tuberculosis.

      Apart from it's protective effect against tuberculosis BCG vaccine has been shown to have
      non-specific effects on the innate immune system and is in epidemiological studies associated
      with reduced mortality due to infectious diseases.

      Several studies have shown that BCG can boost the effect of other vaccines. The present study
      aims to investigate the boosting effect of BCG on the response to typhoid fever vaccine (TFV)
      and to assess the non-specific effects of BCG on the innate immune system at early timepoints
      by vaccinating volunteers with either TFV alone or BCG followed by TFV 14 days later.

      The study hypothesis is that when BCG is given 14 days before typhoid fever vaccine a better
      vaccination result in terms of antibody production will be accomplished against typhoid fever
      due to the effects of BCG on the innate immune system.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anti-salmonella typhi Vi antigen antibody titer 2 weeks post TFV</measure>
    <time_frame>2 weeks</time_frame>
    <description>anti-salmonella typhi Vi antigen antibody titers at 2 weeks after TFV will be compared between TFV only and TFV after BCG groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>anti-salmonella typhi Vi antigen antibody titer 3 months post TFV</measure>
    <time_frame>3 months</time_frame>
    <description>anti-salmonella typhi Vi antigen antibody titers at 3 months after TFV will be compared between TFV only and TFV after BCG groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in ex vivo cytokine responses</measure>
    <time_frame>0, 1 and 4 days; 2 weeks, 3 months</time_frame>
    <description>Ex vivo cytokine response to unrelated antigens</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>BCG Vaccination</condition>
  <arm_group>
    <arm_group_label>TFV alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Typhim Vi</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BCG+TFV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BCG (SSI, Denmark) followed after 14 days by Typhim Vi</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>BCG</intervention_name>
    <arm_group_label>BCG+TFV</arm_group_label>
    <other_name>BCG vaccine (SSI, Denmark)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>TFV</intervention_name>
    <arm_group_label>TFV alone</arm_group_label>
    <arm_group_label>BCG+TFV</arm_group_label>
    <other_name>Typhim Vi</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

        Exclusion Criteria:

          -  Born in Salmonella typhi endemic country

          -  Pregnancy

          -  Oral medication except anticonceptive drugs

          -  Previous vaccination with BCG and/or TFV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihai Netea, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>BCG</keyword>
  <keyword>Salmonella</keyword>
  <keyword>Trained immunity</keyword>
  <keyword>Non-specific effect vaccines</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

